Anonymous3 days ago
Emergency room visits for tick bites are at their highest levels since 2017, with an estimated 476,000 Americans treated for Lyme disease annually and reported cases reaching 89,000 in 2023 — driven by a combination of warmer winters, changing land use, and revised surveillance methods. As Pfizer and Valneva's Lyme disease vaccine candidate shows 73% efficacy in Phase 3 trials, debates over chronic Lyme disease, diagnostic accuracy, and the economic burden exceeding $1 billion annually continue to shape both policy and patient experience.